Condition: Hemorrhoids · Hemorrhoids, Internal · Suture; Complications, Infection or Inflammation · Sponsor: Developeration AB
The SCI-Pex study is a multicenter, prospective, non-controlled investigation on PexyEazy®, a new device for treatment of hemorrhoids based on the mucopexy method. Mucopexy is a well established method where sutures are applied above the hemorrhoids. When knots are tied, the hemorrhoids are lifted inwards to their normal position, which makes them swell down and symptoms disappears. PexyEazy® perform a mukopexy in a semiautomatic, faster and easier way on awake patient in less than 10 minutes. The SCI-Pex study will evaluate the safety and performance of PexyEazy on 35 patients with hemorrhoids grade II and III with a follow-up after 1 week, 3 months and 1 years. Adverse events, pain and other complications will be recorded, quality of life and hemorrhoid symptom questionnaires and clinical examination after 3 months and 1 year will be monitored to evaluate the result after a PexyEazy® procedure.
This description comes directly from the study's public registry record.
Johan Ungerstedt, Dr · +46709427842 · johan.ungerstedt@developeration.se
Ulf Kressner, Dr · ulfkressner@icloud.com
Always discuss trial participation with your own doctor first.
| Frölunda Specialistsjukhus | Frölunda, Sweden | Recruiting |
| Norrtälje Sjukhus | Norrtälje, Sweden | Recruiting |
| Capio kirurgkliniken, Sophiahemmet | Stockholm, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05782010